JPM Thematics - Genetic Therapies C2 Fonds
83,64
CHF
-0,38
CHF
-0,45
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Novartis AG Registered Shares | CH0012005267 | 3,37% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,26% |
| Gilead Sciences Inc | US3755581036 | 3,12% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 3,09% |
| Ionis Pharmaceuticals Inc | US4622221004 | 3,04% |
| Biomarin Pharmaceutical Inc | US09061G1013 | 3,01% |
| Krystal Biotech Inc | US5011471027 | 2,96% |
| Vericel Corp | US92346J1088 | 2,95% |
| Amgen Inc | US0311621009 | 2,94% |
| Bio-Techne Corp | US09073M1045 | 2,87% |
| Sonstige | 69,39% |